DHA and Cognitive Health: What Clinical Research Shows
A balanced look at DHA supplementation and cognitive outcomes, including positive trials, meta-analysis findings and relevance to NeuroVera.
A Positive Memory Trial
A randomized study in 485 older adults with age-related cognitive decline used 900 mg/day DHA for 24 weeks and reported improvement on a selected learning-and-memory measure. This is relevant evidence, but it does not mean lower doses or different populations will produce the same outcome.
What Pooled Evidence Shows
A meta-analysis covering ten studies and more than 2,000 older adults did not find a clear overall cognitive benefit from DHA/EPA supplementation. Mixed trial results are exactly why one positive study should not be treated as the entire evidence base.
Relevance to NeuroVera
The working NeuroVera label information states “DHA 10% 25 mg.” That wording is not equivalent to the hundreds of milligrams of DHA used in many clinical trials. We therefore do not use high-dose DHA trials as direct proof of NeuroVera effectiveness.
Sources & References
- Yurko-Mauro et al. — DHA and age-related cognitive decline (PubMed)
- Meta-analysis of DHA/EPA and cognition (PubMed)
- NCCIH — Dietary Supplements and Cognitive Function
Product pages are used for seller-reported facts such as current formula, price and guarantee. They are not treated as independent proof of effectiveness.